How political attacks could crush the mRNA vaccine revolution
Donald Trump's second term's first day featured a major AI investment, signaling support for transformative mRNA technology intended for personalized cancer treatments.
How political attacks could crush the mRNA vaccine revolution
Donald Trump's second term's first day featured a major AI investment, signaling support for transformative mRNA technology intended for personalized cancer treatments.
In other news this week: BayWa r.e. secures 435M, evroc gets Europe's largest Series A funding, Sofinnova Partners raises 165M and more - Silicon Canals
In other news this week: BayWa r.e. secures 435M, evroc gets Europe's largest Series A funding, Sofinnova Partners raises 165M and more - Silicon Canals
23andMe and its user data will soon belong to a pharmaceutical giant
23andMe will continue its DNA testing services following acquisition by Regeneron Pharmaceuticals, ensuring privacy protections and customer data management remain in place.
23andMe and its user data will soon belong to a pharmaceutical giant
23andMe will continue its DNA testing services following acquisition by Regeneron Pharmaceuticals, ensuring privacy protections and customer data management remain in place.
A cell pulls off one of the 'Holy Grails' of biotechnology
A groundbreaking discovery reveals that a complex single-celled alga can convert nitrogen, potentially revolutionizing agriculture and reducing reliance on synthetic fertilizers.
Startup uses ancient bacteria to turn Texas CO2 into green chemicals
Again is building a new bioreactor plant in Texas to convert CO2 into sustainable chemicals using ancient bacteria, aiming for substantial emissions reduction.
A cell pulls off one of the 'Holy Grails' of biotechnology
A groundbreaking discovery reveals that a complex single-celled alga can convert nitrogen, potentially revolutionizing agriculture and reducing reliance on synthetic fertilizers.
Startup uses ancient bacteria to turn Texas CO2 into green chemicals
Again is building a new bioreactor plant in Texas to convert CO2 into sustainable chemicals using ancient bacteria, aiming for substantial emissions reduction.
Cancer Research in the US Is World Class Because of Its Broad Base of Funding-with the Government Pulling Out, Its Future Is Uncertain - Non Profit News | Nonprofit Quarterly
The complex ecosystem of U.S. cancer research is threatened by funding instability and political shifts.
Cancer Research in the US Is World Class Because of Its Broad Base of Funding-with the Government Pulling Out, Its Future Is Uncertain - Non Profit News | Nonprofit Quarterly
The complex ecosystem of U.S. cancer research is threatened by funding instability and political shifts.
Genetic-engineered bacteria break down industrial contaminants
Researchers have engineered a single bacterial strain capable of degrading multiple industrial contaminants using genes from diverse bacterial species.
Four rising stars at the forefront of cancer research
Young researchers are innovating in cancer drug development, focusing on pioneering techniques like cancer reversion to reduce the need for traditional treatments.
Four rising stars at the forefront of cancer research
Young researchers are innovating in cancer drug development, focusing on pioneering techniques like cancer reversion to reduce the need for traditional treatments.
COVID-flu vaccine could provide broad, lasting protection | Cornell Chronicle
A new vaccine platform from Cornell researchers offers longer-lasting protection against COVID-19 and influenza, showing promising results in mouse models.
Bay Area man who injected himself with venom hundreds of times could revolutionize snakebite treatment
Tim Friede's unique exposure to snake venom has led to the development of an antivenom for 19 snake species, showcasing new possibilities in snakebite treatment.
COVID-flu vaccine could provide broad, lasting protection | Cornell Chronicle
A new vaccine platform from Cornell researchers offers longer-lasting protection against COVID-19 and influenza, showing promising results in mouse models.
Bay Area man who injected himself with venom hundreds of times could revolutionize snakebite treatment
Tim Friede's unique exposure to snake venom has led to the development of an antivenom for 19 snake species, showcasing new possibilities in snakebite treatment.
Ten years ago, I began combining financial modeling expertise with computational biology to create a drug discovery platform. Evolution has spent billions of years perfecting natural defence mechanisms, and now we're using AI to unlock this wisdom.
Fertility startup 'rejuvenates' human eggs to boost chances of conception
Ovo Labs is developing technologies to enhance IVF success rates by rejuvenating human eggs, aiming to lower genetic errors and increase conception chances.
Company Seeking to Resurrect the Woolly Mammoth Creates a 'Woolly Mouse'
Colossal Biosciences introduces lab-created woolly mice as a step toward reviving extinct species, emphasizing genetic engineering's role in enhancing resilience against climate change.
Company Seeking to Resurrect the Woolly Mammoth Creates a 'Woolly Mouse'
Colossal Biosciences introduces lab-created woolly mice as a step toward reviving extinct species, emphasizing genetic engineering's role in enhancing resilience against climate change.
Dutch healthtech startups that raised funding in 2025
The State of Dutch Tech report shows tech companies in the Netherlands raised â¬3.1B in venture capital in 2025, indicating growing confidence in the Dutch innovation ecosystem.
For Patients Needing Transplants, Hope Arrives on Tiny Hooves
Cloned pigs are being raised in controlled conditions for potential use in human organ transplants, highlighting advances in biotechnology and ethical considerations.